SunOpta Inc. (NASDAQ:STKL) shares traded up 2.6% on Monday . The company traded as high as $5.24 and last traded at $5.18, with a volume of 243,355 shares changing hands. The stock had previously closed at $5.05.

A number of research analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of SunOpta from a “sell” rating to a “hold” rating in a report on Wednesday, May 4th. Canaccord Genuity reiterated a “buy” rating and issued a $10.00 target price on shares of SunOpta in a research note on Wednesday, April 13th. DA Davidson upgraded shares of SunOpta from a “neutral” rating to a “buy” rating and set a $6.00 target price on the stock in a research note on Wednesday, April 13th. Finally, AltaCorp Capital reiterated an “outperform” rating on shares of SunOpta in a research note on Tuesday, June 21st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $9.50.

The company’s market cap is $443.79 million. The stock has a 50 day moving average of $4.65 and a 200-day moving average of $5.02.

SunOpta (NASDAQ:STKL) last announced its quarterly earnings data on Tuesday, May 10th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by $0.01. The business had revenue of $352.30 million for the quarter, compared to analysts’ expectations of $351.60 million. During the same quarter last year, the firm earned $0.08 EPS. The firm’s quarterly revenue was up 16.1% on a year-over-year basis. Equities research analysts predict that SunOpta Inc. will post $0.24 earnings per share for the current fiscal year.

In other news, Director Douglas Greene acquired 50,000 shares of SunOpta stock in a transaction on Friday, May 20th. The shares were purchased at an average cost of $3.77 per share, for a total transaction of $188,500.00. Following the completion of the purchase, the director now directly owns 265,543 shares of the company’s stock, valued at approximately $1,001,097.11. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Hendrik Jacobs acquired 7,000 shares of SunOpta stock in a transaction on Friday, May 20th. The shares were purchased at an average price of $3.85 per share, for a total transaction of $26,950.00. Following the completion of the purchase, the chief executive officer now directly owns 41,638 shares of the company’s stock, valued at $160,306.30. The disclosure for this purchase can be found here.

Other hedge funds and institutional investors recently bought and sold shares of the company. Dimensional Fund Advisors LP boosted its position in SunOpta by 56.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 151,928 shares of the company’s stock worth $1,039,000 after buying an additional 54,539 shares during the period. Baker Chad R bought a new position in SunOpta during the fourth quarter worth approximately $2,977,000. Jennison Associates LLC boosted its position in SunOpta by 6.8% in the fourth quarter. Jennison Associates LLC now owns 4,234,596 shares of the company’s stock worth $28,965,000 after buying an additional 270,963 shares during the period. Finally, Morgan Stanley boosted its position in SunOpta by 123,646.6% in the fourth quarter. Morgan Stanley now owns 6,693,454 shares of the company’s stock worth $45,783,000 after buying an additional 6,688,045 shares during the period.

SunOpta Inc operates businesses focused on a healthy products portfolio. The Company operates through two segments: Global Ingredients and Consumer Products. Its Global Ingredients segment aggregates its North American and international raw material sourcing and supply operating segments focused on the procurement, processing and sale of specialty and organic grains and seeds, fruits, grain- and cocoa-based ingredients, and other commodities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.